MICHELLE GULLEY: Open Payments
NPI 1932784345 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 63 payments from 18 companies in 2025. Trend: 2023 $885 · 2024 $803 · 2025 $1,290
Food & beverage: $1,227Education: $62
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $237 |
| Janssen Biotech, Inc. | 8 | $166 |
| ANI Pharmaceuticals, Inc. | 11 | $138 |
| Kerecis Limited | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Amgen Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| GlaxoSmithKline, LLC. | 2 | $55 |
| PFIZER INC. | 3 | $53 |
| Radius Health, Inc. | 2 | $48 |
Products named: TREMFYA, Kerecis SurgiClose, PURIFIED CORTROPHIN GEL, RINVOQ, SKYRIZI, SAPHNELO, BENLYSTA, XELJANZ.
Industry payments across MD — which companies pay providers there.
